Patents
Patents for C07K 19 - Hybrid peptides (29,428)
03/2010
03/31/2010EP2168977A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
03/31/2010EP2167529A1 Protein layers and their use in electron microscopy
03/31/2010EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins
03/31/2010CN101688183A Cancerous disease modifying antibodies
03/31/2010CN101688179A Recombinant protein production in avian ebx r cells
03/31/2010CN101687935A Tgfp-cap peptide and its uses
03/31/2010CN101687933A Immunoglobulin fusion proteins
03/31/2010CN101687931A an anti-cancer cytotoxic monoclonal antibody
03/31/2010CN101684472A Recombinant fusion proteins containing p53 genes, recombinant and application thereof
03/31/2010CN101684470A Novel phospholipases and uses thereof
03/31/2010CN101684161A System for detecting protease
03/31/2010CN101684160A Recombinant protein for diagnosing bovine tuberculosis and application thereof
03/31/2010CN101684159A Protein derivatives of human granzyme B, and use thereof in targeted therapy on adenocarcinoma
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684146A Novel hcv non-structural polypeptide
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/30/2010CA2428642C Methods for large scale production of recombinant dna-derived tpa or k2s molecules
03/30/2010CA2241604C Mesothelium antigen and methods and kits for targeting it
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033854A2 Avian derived fusion proteins
03/25/2010WO2010033031A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2009152364A3 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination
03/25/2010US20100075412 T1r taste receptors and genes encoding same
03/25/2010US20100075394 Method of Crosslinking Two Objects of Interest
03/25/2010CA2738031A1 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
03/25/2010CA2722794A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
03/24/2010EP2166093A1 Pharmaceutical composition for enzyme replacement therapy
03/24/2010EP2164877A1 The puro-dhfr quadrifunctional marker and its use in protein production
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN101679500A G-protein-conjugated receptor having altered ligand affinity, and use thereof
03/24/2010CN101676728A cytokine receptor
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/18/2010US20100068762 Novel nucleic acid molecules
03/18/2010US20100068175 Methods of using Fc-Cytokine fusion proteins
03/18/2010US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects
03/17/2010EP2163618A2 Fluorescent protein
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP2162472A2 Immunoglobulin fusion proteins
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010EP1091971B1 Polyketide synthesis
03/17/2010EP1027439B1 Multivalent antigen-binding proteins
03/17/2010CN101675079A Binding members for ige molecules
03/17/2010CN101671688A Beta 2 adrenergic receptor fused with EGFP, recombination expression carrier and constructing method thereof
03/17/2010CN101671397A Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
03/17/2010CN101671396A Vascular endothelial growth factor specifically combined with collagen and application thereof
03/17/2010CN101671389A Erythrocyte generating characteristic-free erythropoietin with nervous protecting function and application thereof
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/11/2010US20100062514 Rearranged squamous cell carcinoma antigen genes ii
03/11/2010US20100062456 Using g protein coupled receptor to identify modulators of taste signal transduction; generating of taste topographic maps that elucidate relationship between taste cells of tongue and taste sensory neurons in brain
03/11/2010US20100062015 Fusion protein vaccine
03/10/2010EP2161338A1 Isolated mammalian monocyte cell genes; related reagents
03/10/2010EP2161037A2 Camptothecin-Somatostatin conjugates
03/10/2010CN101665539A Restructured fusion protein PTD-MAX and expression method and application thereof
03/10/2010CN101665538A Novel GLP-1 analogues linked to albumin-like agents
03/10/2010CN101665537A Novel apoptosis test regent and related kit
03/10/2010CN100593544C Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674462 Transforming growth factor receptor specific immunoglobulin for use in diagnosis prvention and treatment of tumor disorders; immunotherapy
03/09/2010CA2382464C High-affinity choline transporter
03/04/2010WO2010025421A2 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
03/04/2010WO2010024269A1 Dwarf transgenic plant, and gene for induction of dwarfing
03/04/2010WO2010024118A1 Novel recombinant protein having caspase recruitment domain applied thereto, and use thereof
03/04/2010WO2010023850A1 Method for treating or preventing bladder cancer using the depdc1 polypeptide
03/04/2010WO2010022639A1 Target-specific double-mutant fusion protein
03/04/2010WO2009139599A3 Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010WO2008151440A8 Modifying glycoprotein production in plants
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055091 Novel GL-50 Molecules and Uses Therefor
03/04/2010CA2735522A1 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics
03/03/2010EP0990030B1 Transcriptional activators with graded transactivation potential
03/03/2010CN101663324A Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
03/03/2010CN101659705A Fusion protein for imaging nucleus and chromosomes in living cell
03/02/2010US7671258 Surfactant peptide nanostructures, and uses thereof
03/02/2010US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV)
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7670808 Nucleic acid modifying enzymes
03/02/2010US7670602 Concatameric immunoadhesion molecule
03/02/2010US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab
03/02/2010CA2390659C Ny-eso-1 peptide derivatives, and uses thereof
02/2010
02/25/2010US20100047877 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased
02/25/2010US20100047818 Diagnosis of carcinomas
02/25/2010US20100047267 Staphylococcus aureus proteins and nucleic acids
02/25/2010US20100047171 Fusion Proteins That Contain Natural Junctions
02/25/2010US20100047168 Soluble Zcytor 11 Cytokine Receptors
02/25/2010CA2733902A1 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling
02/24/2010EP2157097A1 Specific binding agents of human angiopoietin-2
02/24/2010EP2155880A1 Modifying glycoprotein production in plants
02/24/2010EP2155792A1 Protein g-oligonucleotide conjugate
02/24/2010EP2155243A2 Compositions and methods comprising klk3, psca, or folh1 antigen
02/24/2010EP1485481B1 Fluorescent protein from aequorea coerulescens and uses thereof
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 295